Current Treatment and Personalized Medicine in Diabetes Mellitus

Diabetes mellitus is a rapidly escalating global health challenge, projected to affect 783 million people by 2045. Both type 1 (T1D) and type 2 diabetes mellitus (T2D) present complex etiologies and heterogeneous clinical outcomes, demanding a shift from conventional treatment paradigms toward more individualized strategies. Current management includes medical nutrition therapy, insulin replacement, delivery innovations, and non-insulin glucose-lowering agents. However, the variability in patient responses underscores the limitations of standardized approaches. Personalized medicine has emerged as a transformative framework, integrating genomics, pharmacogenomics, metabolomics, and advanced technologies to optimize diabetes care. In T1D, predictive biomarkers, continuous glucose monitoring (CGM), and automated insulin delivery systems represent major advancements, offering improved glycaemic control and reduced hypoglycaemia risk. Novel therapies such as stem cell and gene therapy hold promise for β-cell regeneration and restoration of insulin function. In T2D, pharmacogenomic-guided therapy enhances drug efficacy and safety by tailoring treatment to genetic variations influencing drug metabolism and response. Moreover, personalized lifestyle interventions—dietary modifications, physical activity, and behavioural strategies—demonstrate significant benefits in sustaining glycaemic control and improving overall quality of life. Future perspectives in diabetes care lie in the convergence of precision medicine and digital health innovations. The integration of genetic and metabolic profiling with artificial intelligence, wearables, and telemedicine will enable proactive, individualized care that enhances patient adherence and reduces the global disease burden. By bridging conventional therapies with data-driven personalized strategies, precision medicine has the potential to redefine diabetes management, improving millions of people's lives globally in terms of safety, effectiveness, and quality of life.